platoscience.io

What it is

PlatoScience is a professional medical device manufacturer based in Copenhagen, Denmark, founded in 2015. It focuses on developing home transcranial direct current stimulation (tDCS) devices for clinical institutions and researchers. Its core products are divided into two series: PlatoCare for depression treatment and PlatoWork for general research scenarios, with its main offering being remotely manageable home-based tDCS treatment programs.

Core Features & Pricing

The brand provides a complete integrated hardware and software solution: it includes a fully wireless tDCS headset, the PlatoApp for end-users compatible with Android and iOS, and a management backend for clinicians. Users can complete home stimulation sessions via the app, while clinicians can remotely configure stimulation protocols, monitor session data in real time, and record patient adherence data, meeting the data management needs for extended clinic care and academic research. The products comply with EU MDR Class IIa medical device requirements, CE certification, and the ISO 13485 quality management system, so overall safety and compliance reach professional medical grade.

For pricing, the official website does not publish a unified public price list. All purchases require a quote request directly from the official team. There are no hidden recurring costs, so long-term operating costs are fully predictable.

Pros and Cons Analysis

Advantages: The brand has more than a decade of experience and development in the tDCS field, and its product compliance leads the industry, fully meeting the regulatory requirements for professional clinical use and research. The fully wireless at-home design paired with remote management helps clinics extend care beyond hospital walls, while lowering trial and error costs for research institutions. The consumable-free design eliminates the need for follow-up repeated purchases, giving it greater cost advantages over similar products, and it is also more eco-friendly.

Disadvantages: The product has a very niche vertical positioning, it is only available to professional institutions and is not sold directly to general consumers. In addition, it is currently only legally supplied in a small number of regions including the EU, the UK, and the US, so regular users cannot purchase it directly.

Suitable Users & Access from China

The website is currently directly accessible from mainland China. The product is suitable for domestic neuroscience research institutions with needs to conduct tDCS clinical research, and compliant medical institutions interested in offering remote adjunct tDCS treatment for depression. General consumers cannot purchase products directly through this platform.